Latest Content

The primary outcome of the trial is intraocular pressure (IOP) measured using Goldmann Applanation Tonometry (GAT).

A recent study examined the current state of readability in ophthalmic letters addressed to patients following their appointment and provides recommended solutions for improvement.

The WaveDȳn Vision Analyzer measures the eye's full optical error, and the WaveDȳn Advantage service uses those measurements to design a wavefront-guided scleral lens correcting both low- and higher-order aberrations.

Elkins shares the moving realities of volunteering with Remote Area Medical, from patients lining up before dawn to what it takes for an OD to get involved.

Myopia developed in 24.5% of initially nonmyopic male students over 3 years, with the highest risk among those with limited hyperopic reserve.

Leslie Scher, OD, focuses on identifying myopia and recommending treatment as soon as possible. Early intervention is shown to improve outcomes and prevent vision loss, and occurrence of severe ocular conditions.

Hamza Shah, OD, MS, FAAO, and Carolyn Majcher, OD, FAAO, weigh in on the recent FDA approval of the drug, which has been used off-label by compounding pharmacies for nearly 2 decades.

Contact lens technology has expanded beyond refractive error correction.

Catch up on the top stories in optometry during the week of August 3-7.

Harrow will acquire Tyrvaya, the only FDA-approved nasal spray for dry eye disease, from Viatris for around $100 million, complementing its cyclosporine product Vevye.

Findings highlight the need for routine bilateral endothelial assessment in herpetic eye disease.

Myopia-control spectacle lenses reduce short-term progression in children by about 50%, though efficacy and long-term durability vary.

Leslie Scher, OD, discussed the importance of scheduling pediatric comprehensive eye exams. She also shared how her practice manages the influx of patients during the busy back to school season.